JUAN SOSA: Open Payments
NPI 1104351923 · VISALIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$866 in 7 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $498 · 2025 $866
Food & beverage: $866
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 3 | $372 |
| Janssen Pharmaceuticals, Inc | 1 | $139 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $121 |
| Teva Pharmaceuticals USA, Inc. | 1 | $108 |
Products named: LYBALVI, INVEGA SUSTENNA, ARISTADA, REXULTI, CAPLYTA, UZEDY.
Industry payments across CA — which companies pay providers there.
